@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-RMSM6LXT-R
  skos:prefLabel "Adjuvants, Anesthesia"@en, "Adjuvants des anesthésiques"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-B69ZSC8J-T
  skos:prefLabel "Quaternary Ammonium Compounds"@en, "Composés d'ammonium quaternaire"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-QF9FKL3K-W .

jvr:-MSQDMTWZ-7
  skos:prefLabel "Antagonistes muscariniques"@fr, "Muscarinic Antagonists"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-FXD7XKCS-G
  skos:prefLabel "Pyrrolidines"@en, "Pyrrolidines"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-QF9FKL3K-W .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-QF9FKL3K-W
  dc:established "1991-01-01"^^xsd:date ;
  dc:created "1999-01-01"^^xsd:date ;
  mesh:pharmacologicalAction jvr:-RMSM6LXT-R, jvr:-MSQDMTWZ-7 ;
  skos:prefLabel "Glycopyrrolate"@en, "Glycopyrronium"@fr ;
  mesh:allowableQualifier jvr:-XV06LPML-W, jvr:-D0F21513-5, jvr:-TJHVZCRZ-0, jvr:-G30ZJ446-J, jvr:-SBNWSM1T-R, jvr:-R3QWLHRG-V, jvr:-NB0XHT3S-N, jvr:-NHL3D2X0-S, jvr:-G4R176S9-J, jvr:-R0ZCQ8X6-J, jvr:-HQRFT0C6-B, jvr:-WK5F724J-1, jvr:-T9HQD7ST-J, jvr:-FWD2BGQ0-9, jvr:-W6SQV79N-S, jvr:-M63HSDM7-1, jvr:-S0CS1X5R-5, jvr:-NFTHND7Q-8, jvr:-L6C0XPHT-4, jvr:-CB30NGKB-3, jvr:-NKM836P1-M, jvr:-Q3979798-W, jvr:-THHNVC7V-3, jvr:-H7K65Q8S-Z, jvr:-BT300B3G-Q ;
  dc:modified "2020-05-27"^^xsd:date ;
  skos:altLabel "Bromure de glycopyrronium"@fr, "Glycopyrronium Bromide"@en, "596-51-0 (Glycopyrrolate)"@fr, "596-51-0 (Glycopyrrolate)"@en, "A14FB57V1D"@fr, "A14FB57V1D"@en, "Pyrrolidinium, 3-((cyclopentylhydroxyphenylacetyl)oxy)-1,1-dimethyl-, bromide"@en, "V92SO9WP2I"@en, "V92SO9WP2I"@fr ;
  skos:definition "A muscarinic antagonist used as an antispasmodic, in some disorders of the gastrointestinal tract, and to reduce salivation with some anesthetics."@en ;
  a skos:Concept, mesh:Descriptor ;
  skos:hiddenLabel "NVA-237"@en, "Glycopyrronium"@en, "NVA 237"@en, "NVA237"@en ;
  skos:broader jvr:-FXD7XKCS-G, jvr:-B69ZSC8J-T ;
  skos:inScheme jvr: ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D006024> .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .